Literature DB >> 11850077

Interstitial deletion of 20q in a patient with Waldenström macroglobulinemia following chemotherapy.

Melissa M Blann1, Gopalrao V N Velagaleti, David L Morgan, Rodolfo E Martinez, Phillip A Conlin, Vijay S Tonk.   

Abstract

A 76-year-old male with a history of renal insufficiency was found to have anemia, an IgM kappa paraprotein on serum immunofixation studies, absence of lytic bone lesions, and findings in the bone marrow consistent with Waldenström macroglobulinemia (WM). Cytogenetic studies including fluorescence in situ hybridization (FISH) on the post-treatment bone marrow revealed the karyotype 46,XY,del(20)(q13.1q13.3). Less than 70 cases of karyotypic abnormalities in patients with WM have been reported, which have shown no abnormalities specific to WM. Monosomy or trisomy of chromosome 20 has been reported in approximately eight cases, but to our knowledge this is the first case report of an interstitial deletion of 20q, confirmed by FISH using chromosome 20 subtelomeric specific probes. Interstitial deletions of 20q are known to occur in polycythemia vera and other hematological malignancies, especially those of myeloid origin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850077     DOI: 10.1016/s0165-4608(01)00538-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  1 in total

1.  Concurrent Waldenstrom's Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation.

Authors:  Peter A DeRosa; Kyle C Roche; Victor E Nava; Sunita Singh; Min-Ling Liu; Anita Agarwal
Journal:  Curr Oncol       Date:  2022-06-29       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.